Sulfonylureas versus metformin and the risk of ventricular arrhythmias among people with type 2 diabetes: a population‐based cohort study
Islam N, Reynier P, Douros A, et al.
Diabetes Obes Metab. Pub. online 1 Feb 2023.
Leggi
Breaking news
Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial
Gullaksen S, Vernstrøm L, Sørensen SS, et al.
Diabetologia. Pub. online 6 Feb 2023.
Leggi
Extended use of an open-source automated insulin delivery system in children and adults with type 1 diabetes: The 24-week continuation phase following the CREATE randomized controlled trial
Burnside M, Lewis D, Crocket H, et al.
Diabetes Technol Ther. Pub. online 10 Feb 2023.
Leggi
Islet autoantibody standardization program: interlaboratory comparison of insulin autoantibody assay performance in 2018 and 2020 workshops
Marzinotto I, Pittman DL, Williams AJK, et al.
Diabetologia. Pub. online 10 Feb 2023.
Leggi
Pregnancy after bariatric surgery
Fisher SA, Stetson BT, Kominiarek MA
JAMA. Pub. online 10 Feb 2023.
Leggi
Meta‐analysis of head‐to‐head clinical trials comparing incretin‐based glucose‐lowering medications and basal insulin – an update including recently developed GLP‐1 receptor agonists and the GIP/GLP‐1 receptor co‐agonist tirzepatide
Nauck MA, Mirna AEA, Quast DR
Diabetes Obes Metab. Pub. online 26 Jan 2023.
Leggi
Four-year visual outcomes in the protocol W randomized trial of intravitreous aflibercept for prevention of vision-threatening complications of diabetic retinopathy
Maturi RK, Glassman AR, Josic K, et al.
JAMA. 2023;329(5):376-385.
Leggi
Integrated safety and efficacy analysis of dasiglucagon for treatment of severe hypoglycaemia in individuals with type 1 diabetes
Heller S, Battelino T, Bailey TS, et al.
Diabetes Obes Metab.Pub. online 24 Jan 2023.
Leggi
Associations of disordered eating with the intestinal microbiota and short-chain fatty acids among young adults with type 1 diabetes
Igudesman D, Crandell J, Corbin KD, et al.
Nutr Metab Cardiovasc Dis. 2023;33(2):388-398.
Leggi
LDL-cholesterol control in the primary prevention of cardiovascular diseases: An expert opinion for clinicians and health professionals
Poli A, Catapano AL, Corsini A, et al.
Nutr Metab Cardiovasc Dis. 2023;33(2):245-257.
Leggi